Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance.
暂无分享，去创建一个
A. Abbruzzese | M. Caraglia | B. Vincenzi | R. Addeo | G. Cennamo | S. D. Del Prete | R. Guarrasi | L. Montella | M. Lanna | V. Faiola | S. Bellini | A. Miragliuolo | Sergio Bellini